Regulatory shifts and new technologies are reshaping radiotherapy practice and purchasing decisions. Against this backdrop SFRO Congres 2026 takes place from 4 to 6 November 2026 at CNIT Forest in Paris, bringing focused scientific sessions and operational debate.
Key dates and venue
The congress runs from 4 to 6 November 2026 at CNIT Forest in Paris. Important pre-event dates include the call for abstracts opening on 2 April 2026 and the abstract submission deadline on 29 May 2026. Registrations open on 20 July 2026 and the e-congress platform becomes available on 23 September 2026.
Scientific program highlights
The 2026 program covers technological innovation and clinical advances. Announced topics include a session on reirradiation in partnership with ESTRO, a dedicated brachytherapy track, and discussion on treatment de-escalation. Organ-specific sessions include breast cancer and a joint session with AFU on bladder cancer. Regulatory and organizational issues are addressed with a session on billing reform and the PLFSS.
Attendee profile and key figures
This edition brings together clinical and technical radiotherapy professionals. Published figures list 1,400 participants, 272 presentations and 52 partners. Attendees include radiation oncologists, medical physicists, technologists and quality managers making the exhibition relevant for devices, software and service providers with both technical and operational value propositions.
Practical B2B prospecting advice
For commercial teams targeting radiotherapy units focus on segmenting clinical, physics and management contacts. Prioritize short technical demos and evidence-based materials that combine clinical outcomes and cost considerations. Use the e-congress platform from 23 September 2026 to request meetings in advance. Details on exhibition space and partnership levels are available under Exposition & Partenariat for companies evaluating sponsorship.
Human and regulatory topics to factor in
The program includes sessions on inclusion and diversity, staff mental health and patient cognitive vulnerabilities. Artificial intelligence will be discussed from ethical and practical viewpoints. Vendors should prepare to address compliance, clinical validation and staff wellbeing in conversations with potential buyers.
Final note and reference
The 37th edition provides a compact view of scientific, regulatory and organizational trends affecting radiotherapy. Review the detailed program and partnership conditions on the official site https://www.sfro-congres.fr/ and align your participation with the abstract and registration deadlines.
Imágenes
